All content and media by Project 100 is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice.

****

Professor Matthew Kiernan is CEO of Neuroscience Research Australia and one of the nation's leading neurologists tackling the growing dementia crisis.

Kiernan explores why dementia is now Australia's number one cause of death, the modifiable risk factors that could prevent 45% of cases, and the groundbreaking monoclonal antibody treatments now available for Alzheimer's disease.

Kiernan explains how the Western Pacific region carries 60% of the world's dementia burden and why researchers are racing to develop blood biomarkers that could detect brain diseases decades before symptoms appear. We also get into:
• Why dementia has overtaken heart disease as Australia's leading killer 
• The role of vascular health in brain function and cognitive decline 
• Blood biomarkers coming within five years for early detection 
• Monoclonal antibody treatments for Alzheimer's now available in Australia 
• The connection between contact sports, head injuries and neurodegeneration 
• How GLP-1 medications are showing promise for brain health 
• Sleep's critical role in clearing toxic proteins from the brain 

Join my exclusive Mentored+ community: https://mentored.com.au/become-a-member/
Subscribe to the Mentored newsletter here: https://mentored.com.au/newsletter

All content and media by Project 100 is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice.
**** Professor Matthew Kiernan is CEO of Neuroscience Research Australia and one of the nation's leading neurologists tackling the growing dementia crisis.
Kiernan explores why dementia is now Australia's number one cause of death, the modifiable risk factors that could prevent 45% of cases, and the groundbreaking monoclonal antibody treatments now available for Alzheimer's disease.
Kiernan explains how the Western Pacific region carries 60% of the world's dementia burden and why researchers are racing to develop blood biomarkers that could detect brain diseases decades before symptoms appear. We also get into: &bull; Why dementia has overtaken heart disease as Australia's leading killer &bull; The role of vascular health in brain function and cognitive decline &bull; Blood biomarkers coming within five years for early detection &bull; Monoclonal antibody treatments for Alzheimer's now available in Australia &bull; The connection between contact sports, head injuries and neurodegeneration &bull; How GLP-1 medications are showing promise for brain health &bull; Sleep's critical role in clearing toxic proteins from the brain Join my exclusive Mentored+ community: <a href="https://mentored.com.au/become-a-member/">https://mentored.com.au/become-a-member/</a> Subscribe to the Mentored newsletter here: <a href="https://mentored.com.au/newsletter">https://mentored.com.au/newsletter</a>

Too often, we avoid real conversations. Entrepreneur Mark Bouris sits down and gets to know people, understands what makes them tick, and shares the great and unusual things they’re doing. There’s no sugar coating. There’s no hiding behind fancy marketing slogans. Just an honest conversation.

Too often, we avoid real conversations. Entrepreneur Mark Bouris sits down and gets to know people, understands what makes them tick, and shares the great and unusual things they&rsquo;re doing. There&rsquo;s no sugar coating. There&rsquo;s no hiding behind fancy marketing slogans. Just an honest conversation.

Straight Talk with Mark Bouris

Brain Expert: Why Dementia Is Australia's Number One Killer (Project 100)

https://api.omny.fm/orgs/2fb3740d-3436-44af-8cc0-a91900716aa5/clips/3e4770d4-dce1-4ae3-8cab-b4520082dae2/transcript